Facebook

All categories

  • All categories
  • Flow Cytometry Antibodies
  • Immunoassays
  • Cell Isolation and Identification
  • Cell Health and Metabolism Assay Kits
  • Cell Culture
  • Antibodies and Reagents
  • Proteins and Peptides
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • Ⅰ
  • Ⅱ
  • Ⅲ
  • Ⅳ
  • Ⅴ
  • Ⅵ
  • Ⅶ
  • Ⅷ
  • Ⅸ
  • Ⅹ
  • Ⅺ
  • Ⅻ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Human FGL1(Fibrinogen Like Protein 1) ELISA Kit (E-EL-H1667)

All Size Price Qty
96T $ 609.00
- +
48T $ 487.00
- +
24T $ 150.00
- +
96T*5 Inquire /
96T*10 Inquire /
Add to cart

For research use only.

Product Summary
Sensitivity 0.1 ng/mL
Detection Range 0.16-10 ng/mL
Sample Volume 100 μL
Total Assay Time 3 h 30 min
Reactivity Human
Specificity This kit recognizes Human FGL1 in samples. No significant cross-reactivity or interference between Human FGL1 and analogues was observed
Recovery 80%-120%
Sample Type Serum, EDTA plasma, heparinized plasma, Saliva, breast milk, Urine and Cell culture supernatant
Detection Method Colorimetric method, ELISA, Sandwich
Assay Type Sandwich-ELISA
Size 96T / 48T / 24T / 96T*5 / 96T*10
Storage 2-8℃
Expiration Date 12 months
Typical data
The following data was generated by the Quality Control Department, under controlled laboratory conditions (ambient temperature: 18-25 °C, relative humidity: 35-75%) using standardized procedures (TMB reaction at 37 °C in the dark for 15 minutes, followed by termination and OD measurement). These values are provided for reference only. Actual results may vary due to differences in laboratory conditions, operator technique, and equipment. Users are required to generate a standard curve using their own experimental data.
ng/mL OD1 OD2 Mean OD Corrected OD
10 2.287 2.333 2.310 2.217
5 1.601 1.597 1.599 1.506
2.5 0.937 0.955 0.946 0.853
1.25 0.512 0.532 0.522 0.429
0.63 0.326 0.336 0.331 0.238
0.32 0.203 0.197 0.200 0.107
0.16 0.149 0.149 0.149 0.056
0 0.096 0.090 0.093 -
Sample Values
EDTA plasma:This kit has been validated using samples from apparently healthy individuals. The data is for reference only.
Serum:This kit has been validated using samples from apparently healthy individuals. The data is for reference only.
Sample Type Sample Size Range Recommended Dilution Factor
Human EDTA plasma 30 168.47-5480.37 ng/mL 100-1000
Human Serum 30 175.92-2957.93 ng/mL 100-1000
Urine:This kit has been validated using samples from apparently healthy individuals. The data is for reference only.
Precision
Intra-assay Precision (Within-run Precision): Three samples representing low, mid, and high concentrations of Human FGL1 were tested 20 times on a single plate.
Inter-assay Precision (Between-run Precision): Three samples representing low, mid, and high concentrations of Human FGL1 were tested on three separate plates, with 20 replicates per plate, to assess variability among assays.
/ Intra-assay Precision Inter-assay Precision
Sample 1 2 3 1 2 3
Numbers 20 20 20 20 20 20
Mean(ng/mL) 0.460 1.070 3.710 0.440 1.090 3.770
Standard deviation 0.020 0.060 0.170 0.030 0.100 0.230
CV(%) 4.250 5.380 4.510 6.590 8.870 6.120
Recovery
The recovery of Human FGL1 was evaluated by spiking samples at low, mid, and high concentrations across the assay range in various sample matrices.
The assay performance was assessed by comparing the measured concentrations to the expected spiked amounts to determine the percent recovery.
Sample Type Range (%) Average Recovery(%)
Cell culture media (n=8) 93-110 100
Serum (n=8) 90-108 98
EDTA plasma (n=8) 86-100 92
Linearity
Linearity of the assay was evaluated by spiking samples with high concentrations of Human FGL1 and performing serial dilutions using Standard & Sample Diluent to produce concentrations spanning the assay's dynamic range. The measured values were then compared to the expected concentrations to assess the linearity of response.
/ / Cell culture media
(n=5)
EDTA plasma
(n=5)
Serum
(n=5)
1:2 Range 88-103 99-113 84-98
Average 94 105 90
1:4 Range 86-102 86-97 94-109
Average 93 92 100
1:8 Range 83-97 82-94 90-107
Average 90 86 97
Stability
Each kit batch is subjected to accelerated stability testing and real-time stability monitoring. Sample performance is evaluated after storage at 37 °C for 10 days to assess the impact of elevated temperature on assay reliability and reagent integrity.
/ Variation range of 37°C mean
concentration / 2-8°C mean
Sample 1(n=16) 91.38-109.95
Sample 2(n=16) 87.71-100.34
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FGL1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FGL1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FGL1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FGL1. You can calculate the concentration of Human FGL1 in the samples by comparing the OD of the samples to the standard curve.
Fibrinogen-like protein 1 (FGL1), also named hepassocin, is a secreted glycoprotein of the fibrinogen superfamily whose C-terminal region contains a conserved fibrinogen-like domain but lacks the sites required for fibrin clot formation. It is synthesized and secreted predominantly by hepatocytes as a disulfide-linked homodimer, and its production is regulated by hepatocellular stimuli, nutritional state and the regenerative status of the liver. FGL1 acts as a hepatocyte mitogen: its expression rises during liver regeneration after partial hepatectomy and is induced by interleukin-6 through STAT3 signaling. More recently FGL1 has been identified as a major ligand of the immune checkpoint receptor lymphocyte-activation gene 3 (LAG-3), which it engages independently of MHC class II to inhibit T-cell activation, proliferation and cytokine production, thereby linking hepatic regeneration with the regulation of anti-tumor immunity. Elevated plasma FGL1 in cancer patients correlates with poor prognosis and resistance to anti-PD-1 or anti-PD-L1 therapy, and blockade of the FGL1-LAG-3 axis can restore T-cell-mediated anti-tumor responses, making FGL1 both a biomarker and an immunotherapeutic target. Measurement of FGL1 supports identification of patients with altered LAG-3 signaling, evaluation of immune checkpoint resistance and development of immunotherapeutic strategies.
Gene ID 2267
Uniport ID Q08830
Research Area Cardiovascular
Product Recommendations for Literature Synchronization

Note: Data for this module come from published literature that cites this product, displaying other products used together in the same research paper.

Reactivity

{{relatedElisaPage.numTotal}} Results

Human FGL1(Fibrinogen Like Protein 1) ELISA Kit - procedures
  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.sample_type}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

No files available. Please enter the correct identification code in the search area to query the relevant documents.

empty
Product Information
Title Status Valid until Action
{{v.文件名}} {{v.status_str}} {{v.timestamp_str}} Download /

*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.

确定